Cargando…
Possible immunotherapeutic potentiation with D-Fraction in prostate cancer cells
BACKGROUND: Prostate cancer remains the most common malignancy among elderly men and the second leading cause of cancer death in the United States. Although several conventional therapies are currently available, they have a low efficacy and the more effective treatment modalities need to be establi...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613393/ https://www.ncbi.nlm.nih.gov/pubmed/19055833 http://dx.doi.org/10.1186/1756-8722-1-25 |